aryl hydrocarbon receptor (AHR), an intracellular chemosensor that regulates xenobiotic metabolism, environmental stress responses, and immune functions. Upon liganddependent activation, the AHR translocates into the nucleus and dimerizes with the AHR nuclear translocator (ARNT) to modulate the expression of its target genes. In addition, AHR activation is frequently accompanied by an activation of the tyrosine kinase c-Src, resulting in stimulation of cellsurface receptors and downstream signal transduction. As PP2 activates the AHR/ARNT pathway by simultaneously blocking c-Src-mediated alternative signaling routes, this compound may be a suitable tool to study the contribution of the different AHR-dependent signaling pathways to biological processes and adverse outcomes. On the other hand, the unexpected property of PP2 to stimulate AHR/ARNT signaling should be carefully taken into account in future investigations in order to avoid a false interpretation of experimental results and molecular interrelations. 
Introduction
The aryl hydrocarbon receptor (AHR) is a ligand-activated transcription factor of the basic Helix-Loop-Helix PAS protein family, whose members regulate gene expression in response to developmental and environmental signals (Gu et al. 2000) . In absence of a ligand, the AHR is present in a cytosolic multiprotein complex consisting of heat-shock protein 90, AHR-interacting protein, and co-chaperone p23. Upon ligand binding, the AHR translocates into the nucleus, sheds its co-chaperones upon heterodimerization with the AHR nuclear translocator (ARNT) protein, and binds to xenobiotic-responsive elements (XRE) in the promoter region of target genes to induce their expression. The AHR gene battery encodes for xenobiotic-metabolizing enzymes, such as cytochrome P450 (CYP) 1A1, as well as for proteins involved in regulation of proliferation, differentiation, and apoptosis (Abel and Haarmann-Stemmann 2010) .
The AHR is activated by a broad spectrum of environmental pollutants, including dioxins and polycyclic aromatic hydrocarbons (PAHs) (Abel and Haarmann-Stemmann 2010; Denison et al. 2011) , and gene-targeting studies in rodents have identified the AHR as an essential mediator of dioxin toxicity and PAH carcinogenicity (Shimizu et al. 2000; Ohtake et al. 2003; Mimura et al. 1997; FernandezSalguero et al. 1996) . In addition, the AHR in keratinocytes is activated upon solar ultraviolet (UV) B irradiation to initiate parts of the cellular UVB stress response, e.g., induction of pro-inflammatory cyclooxygenase-2 (Fritsche et al. 2007 ). The initial event for this UVB-mediated AHR activation is the absorbance of UVB rays by free tryptophan followed by the intracellular formation of the tryptophan photoproduct 6-formylindolo [3,2b] carbazole, a high-affinity AHR ligand (Fritsche et al. 2007; Rannug et al. 1995) . Mechanistic studies aiming to elucidate the complex processes triggering both dioxin toxicity and cutaneous UVB stress responses have brought to light the fact that the AHR may signal not only in an ARNT-dependent manner, but also through an alternative pathway (Matsumura 2009; Haarmann-Stemmann et al. 2009 ). Activation of the AHR leads to a rapid activation of the soluble tyrosine kinase c-Src, which is either directly or indirectly associated with the cytosolic AHR multiprotein complex (Dong et al. 2011; Park et al. 2007) . Activated c-Src can translocate to the plasma membrane and phosphorylate cell-surface receptors, such as the epidermal growth factor receptor, which leads to the subsequent stimulation of downstream mitogen-activated protein kinase (MAPK) signal transduction to modulate transcription of genes, such as cyclooxygenase-2 (Fritsche et al. 2007; Vogel et al. 2000) .
As c-Src is the molecular link between ligand-mediated AHR activation and accompanied epidermal growth factor receptor phosphorylation, chemical inhibitors of this tyrosine kinase are frequently used to study an involvement of alternative AHR signaling in certain cellular processes (Xie et al. 2012; Tomkiewicz et al. 2013; Randi et al. 2008; Fritsche et al. 2007 ). One of the most prominent compounds used to inhibit c-Src and related Src family kinases (SFKs) is 4-amino-5-(4-chlorophenyl)-7-(dimethylethyl)pyrazolo [3,4-d] pyrimidine, also known as PP2 (Fig. 1a) (Hanke et al. 1996) . SFK activity is regulated by phosphorylation and dephosphorylation of a specific tyrosine residue (e.g., Y530 for c-Src), which is triggered by C-terminal Src kinase and protein tyrosine phosphatases (Wheeler et al. 2009 ). Phosphorylation of this tyrosine residue results in inactivation of the SFK, whereas its dephosphorylation leads to a destabilization of intramolecular interactions and a subsequent autophosphorylation of another tyrosine residue (e.g., Y416 for c-Src). This ATP-dependent autophosphorylation triggers conformational opening of the SFK molecule and enables its interaction with receptor tyrosine kinases, cytokine receptors, G-protein-coupled receptors, and other signaling molecules (Wheeler et al. 2009 ). PP2 can now bind to the ATPbinding site in the catalytic center of the SFK and thereby inhibits the kinase-activating process of autophosphorylation (Karni et al. 2003 ).
In the current study, we identify activation of AHR signaling as an off-target effect of PP2 in two human immortalized cell lines and further define this compound as a true ligand of AHR.
Results and discussion
While studying the role of alternative AHR signaling in UVB-irradiated keratinocytes using different protein kinase inhibitors, we unexpectedly observed a transcriptional induction of CYP1A1 in PP2-treated, sham-irradiated cells. To clarify whether PP2 activates canonical AHR signaling and to exclude that the observed effect was celltype specific, we performed reporter gene assays in XREHepG2 cells. These cells contain a stable integrated luciferase reporter construct driven by two XREs (Gradin et al. 1993; Haarmann-Stemmann et al. 2010) . A 24-h exposure of XRE-HepG2 cells to different concentrations of PP2 resulted in a dose-dependent increase in luciferase activity, thereby confirming that PP2 stimulates AHR-dependent transcription (Fig. 1b) . Whereas treatment of the cells with 1 µM of the PAH and model AHR agonist benzo(a)pyrene (BaP) resulted in a 21-fold induction of luciferase activity, an exposure to 5 µM and 10 µM PP2 led to a 4.5-fold and 6.5-fold increase of the response, respectively. To demonstrate the AHR-dependency of the PP2-mediated induction of luciferase activity, we treated XRE-HepG2 cells for 1 h with 3′-methoxy-4′-nitroflavone (MNF), an established AHR antagonist (Lu et al. 1995) , prior to PP2 exposure. As expected, the reporter gene activity of cells exposed to 10 µM MNF and 10 µM PP2 was significantly reduced compared to the cells treated solely with PP2 (Fig. 1b) . These results suggest that the PP2-induced increase in promoter activity is due to a direct binding of PP2 to the AHR protein. To confirm these data, we treated HepG2 cells with 10 µM PP2 or solvent and measured gene expression of the AHR prototype target gene CYP1A1 by quantitative real-time PCR. PP2 exposure resulted in a time-dependent increase of CYP1A1 mRNA. After 24 h, CYP1A1 gene expression was approximately 15-fold elevated with PP2, whereas incubation with 1 µM BaP led to a roughly 150-fold induction (Fig. 1c) . To exclude the possibility that PP2 increased the expression level of AHR or ARNT and thereby just indirectly raised XRE-dependent gene expression, we compared the expression of both genes in solvent-and PP2-treated HepG2 cells. Notably, an exposure for 24 h to 10 µM PP2 had no effect on AHR and ARNT mRNA expression (Fig. 1d) .
Next, we investigated the effect of PP2 treatment on CYP1A1 transcript levels in AHR-proficient and AHRknockdown keratinocytes. More precisely, we used human non-malignant NCTC 2544 keratinocytes, which were stably transfected with an AHR-targeting shRNAconstruct (NCTC-shAHR) or the respective empty vector (NCTC-EV), as described previously (Frauenstein et al. 2013 ). Exposure of NCTC-EV cells to 10 µM PP2 for 6 h resulted in a slight but significant induction of CYP1A1 mRNA (Fig. 2a) . After 24 h of treatment, the message was approximately 25-fold enhanced. As expected, PP2 treatment of NCTC-shAHR cells did not alter CYP1A1 mRNA levels ( Fig. 2a) , demonstrating that the PP2 effect on CYP1A1 was AHR-dependent. To ensure that the observed alterations on CYP1A1 mRNA levels are translated to functional level, we performed ethoxyresorufin-O-deethylase (EROD) assays to measure CYP1A enzyme activity. An exposure to increasing concentrations of PP2 (1, 5, 10 µM) for 24 h significantly induced EROD activity in NCTC-EV cells in a dose-dependent manner (Fig. 2b) . In comparison with solvent-treated cells, EROD activity was tenfold enhanced by 10 µM PP2, whereas 1 µM BaP exposure elevated EROD activity roughly 20-fold. A 1-h pre-treatment with 10 µM MNF completely abolished PP2-and BaPinduced CYP1A enzyme activities. Accordingly, PP2 treatment did not affect CYP1A activity in NCTC-shAHR cells, but notably the residual AHR level in these cells [approximately 20 % (Frauenstein et al. 2013) ] was still sufficient to marginally induce EROD activity in response to BaP exposure (Fig. 2c) . These results confirm the observed PP2-mediated and AHR-dependent increase in CYP1A1 expression and indicate that PP2 usage may potentially influence experimental results by modulating the CYP1A-driven metabolism of endogenous substrates and co-administered chemicals and drugs. In addition, the PP2-activated AHR may also modulate the expression of genes encoding proteins regulating other cellular functions, or it may affect the activity of interacting transcription factors (e.g., NF-κB, hypoxia-inducible factors, estrogen receptors) (Abel and Haarmann-Stemmann 2010; Denison et al. 2011) .
To ensure that PP2 stimulates the DNA-binding activity of AHR/ARNT, we performed electrophoretic mobility shift assays (EMSA) using a radioactive-labeled XREcontaining oligonucleotide. Nuclear extracts from HepG2 cells incubated in the absence or presence of 1nM of the prototype AHR ligand 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) resulted in a inducible protein-DNA complex, representing the TCDD:AHR/ARNT:XRE complex (Fig. 3) . Nuclear extracts of cells incubated with 10 µM PP2 revealed an induced protein-DNA complex of lower intensity that migrated to the same position as that from TCDD-treated cells, and which completely disappeared when cells were co-incubated with 10 µM MNF. The addition of antibodies targeting either AHR or ARNT to the nuclear extracts of PP2-treated HepG2 cells led to a supershift of the band, demonstrating that the induced protein-DNA complexes contained both AHR and ARNT. Thus, PP2 activates the AHR and stimulates the formation of a nuclear AHR/ARNT heterodimer that recognizes its DNA target motif to modulate gene expression. Notably, the lower band observed in the EMSA may represent a binding complex of AHR containing other partner proteins (i.e., Rel proteins), as described earlier (Vogel et al. 2007 ). To assess whether PP2 activates AHR in a ligand-dependent manner, we performed competitive ligand-binding assays using guinea pig hepatic cytosol. As shown in Fig. 4 , the addition of 1 and 10 µM PP2 competitively reduced the specific binding of [ 3 H]TCDD to AHR protein by 13 and 60 %, respectively. Notably, the co-incubation with 100 µM PP2 resulted in a complete displacement of [ 3 H]TCDD specific binding from the AHR. These concentration-dependent effects confirm that PP2 is indeed an AHR ligand.
Src family kinases constitute a major group of nonreceptor tyrosine kinases, and its members play crucial roles in signal transduction and thus are of fundamental importance for numerous biological functions, including proliferation, differentiation, adhesion, migration, apoptosis, autophagy, and angiogenesis (Wheeler et al. 2009 ). c-Src was the first SFK discovered as the cellular form of the transforming gene product v-Src of the avian Rous sarcoma virus (Brown and Cooper 1996) . Meanwhile, ten SFKs were identified, differing in their tissue distribution pattern: Whereas c-Src, Fyn, and Yes are ubiquitously expressed, the expression of Blk, Fgr, Hck, Lck, Yrk, and Lyn is restricted to hematopoietic cells and that of Frk to cells of epithelial origin (Wheeler et al. 2009 ). Multiple studies provided evidence that c-Src and other SFKs are involved in the development, progression, and metastasis of several human malignancies, including prostate, breast, colon, head and neck, lung, and pancreatic cancer (Kim et al. 2009; Saito et al. 2010; Wheeler et al. 2009 ). Accordingly, the elucidation of the functional roles of SFKs under physiological and pathophysiological conditions is of high priority. Hence, SFK inhibitors, such as PP2, are frequently used tools to dissect SFK function. As the AHR and its binding partner ARNT are expressed in nearly all normal and malignant cell types and tissues (Abel and HaarmannStemmann 2010; Safe et al. 2013) , it cannot be excluded that some of the experimental observations made in PP2-exposed cells or tissues were not due to PP2-mediated SFK inhibition, but to a PP2-initiated activation of canonical AHR signaling. Moreover, as-yet-unexplained experimental observations, such as the PP2-mediated enhancement of lipopolysaccharide-induced interleukin (IL)-6 expression in macrophages (Nguyen et al. 2010 ), could be due to the PP2-driven activation of AHR signaling as well. Indeed, a comparable synergistic induction of IL-6 was recently identified in MCF-7 cells co-exposed to TCDD and NF-κB-stimulatory IL-1β, and it likely involved a cross-talk between AHR and RelA (DiNatale et al. 2010) . On the other hand, the property to activate canonical AHR signaling with simultaneous inhibition of the c-Src-dependent alternative AHR pathways may recommend PP2 as a useful tool for mechanistic studies of AHR biology.
The vast majority of chemicals designed to interfere with protein kinase activity act through binding to the ATPbinding site of the respective enzyme (Bain et al. 2007 ). Accordingly, putative kinase inhibitors are limited in their 3 H]TCDD in the presence of 1, 10, or 100 µM PP2. Samples are analyzed by the hydroxyapatite assay as described under Materials and Methods. Specific binding is determined as a difference between total and non-specific binding reactions. The values are presented as mean (±standard deviation) of three independent reactions. *Significantly different from the 'no competitor' reaction. Representative results of two independent experiments are shown size and structural diversity, implying that other kinase blockers may also interact with AHR. In fact, an increasing number of protein kinase inhibitors have been identified as modulators of AHR activity. For instance, the p38 MAPK inhibitor SB203580 (Korashy et al. 2011 ) and the MAPK kinase inhibitor PD98059 (Reiners et al. 1998 ) as well as the chemotherapeutic drug and broadband receptor tyrosine kinase inhibitor sunitinib (Maayah et al. 2013) , were described to affect the AHR in an either agonistic or antagonistic manner. Beside the potential of misinterpreting experimental data, an unpredicted modulation of AHR activity by clinically applied protein kinase inhibitors may contribute to the development of toxic side effects (CYP1A-mediated drug-drug interactions, adverse skin reactions, and alterations of immune and endocrine functions) that may adversely affect patients' health. Noteworthy, it remains to be clarified whether the concentrations of PP2 or other protein kinase inhibitors that may be reached in in vivo experiments or clinical settings are still sufficient to alter AHR activity. In any case, the potential of small molecular weight protein kinase inhibitors to modulate AHR activity and downstream signaling events should be taken into consideration in future research investigations and drug safety assessments.
Materials and methods

Cell culture and treatment
HepG2 cells and XRE-HepG2 reporter cells were cultured in RPMI-1640 medium (PAA, Coelbe, Germany) containing 3.7 % NaHCO 3 (w/v), 10 % FCS (v/v), and 1 % (v/v) antibiotic/antimycotic solution. Culture medium for XRE-HepG2 cells was supplemented with 0.8 mg/ml G418 (AppliChem, Darmstadt, Germany). NCTC-EV and NCTC-shAHR cells were cultured in MEM medium (PAA) supplemented with 10 % FCS (v/v), 1 % antibiotic/antimycotic solution (v/v), and 0.84 mg/ml G418. All cells were cultivated in a humidified atmosphere of 5 % CO 2 at 37 °C. PP2, BaP (Sigma-Aldrich, Munich, Germany), and MNF were dissolved in DMSO. For AHR antagonism, cells were pretreated for 1 h with MNF before the other test compounds were added as indicated.
Reporter gene assay
For reporter gene analyses, 1 × 10 5 XRE-HepG2 cells/ well were seeded in 12-well plates and cultured overnight. Cells were treated as indicated, and 24 h later, cell lysates were prepared and luciferase activities were determined using the luciferase assay system (Promega, Mannheim, Germany) in a Multi-Bioluminat LB 9505C (Berthold, Wildbad, Germany). Protein concentrations were determined using the BC Assay protein quantification kit (BioRad). Luciferase activities were normalized against protein content.
Quantitative real-time PCR
For quantitative gene expression analyses, 3 × 10 5 cells/ well were seeded into six-well plates, cultured overnight and treated at a confluence of approximately 70 % as indicated. Total RNA was isolated using the Gold RNA kit (Peqlab, Erlangen, Germany). For each sample, 0.5 µg of total RNA was reverse-transcribed using MMLV reverse transcriptase (Invitrogen, Karlsruhe, Germany) in a total volume of 20 µl. Three microliters of cDNA of a 1:3 dilution were used for real-time PCR with SYBR Fast Reagent (Qiagen, Hilden, Germany) in a Rotor Gene Q real-time PCR cycler (Qiagen). Gene expression was normalized to β-actin. The oligonucleotide sequences used were published previously ).
Ethoxyresorufin-O-Deethylase (EROD) assay
For measuring CYP1A1 activities in living monolayer keratinocyte cultures, ethoxyresorufin (Sigma-Aldrich; solved in DMSO) was employed according to a protocol described in Rolsted et al. (2008) . Standard curves were generated with pure resorufin dissolved in the respective media or assay solution. Briefly, serum-free media containing 2.5 µM ethoxyresorufin and 10 µM dicumarol were applied to PBS-washed monolayer cells, and resorufin formation kinetics were measured after incubation for 21 min at 37 °C using excitation and emission wavelengths of 544 and 590 nm, respectively, on a Fluoroskan Ascent reader (Labsystems, Bornheim, Germany). Prior to this analysis, cells were treated with PP2, BaP, and/or MNF, as indicated, for 24 h. All experiments were carried out three times in triplicate.
Electrophoretic mobility shift assay (EMSA) Isolation of nuclear extracts and EMSAs were carried out as described previously (Vogel et al. 2007) . TCDD was obtained from Dow Chemical Co. (Midland, MI). The antibodies against AHR and ARNT used for supershift analyses were purchased from Novus Biologicals (Littleton, CO) and Santa Cruz Biotechnology (Santa Cruz, CA), respectively.
AHR ligand-binding assay
The competitive displacement of [ 3 H]TCDD (specific activity 10.7 Ci/mmol) from guinea pig hepatic cytosol was performed as described earlier (Korashy et al. 2011; Denison et al. 1986 ). Briefly, guinea pig cytosol was diluted to 8 mg protein/ml with MEDG (25 mM MOPS, pH 7.5, 1 mM EDTA, 1 mM DTT, 10 % (v/v) glycerol) and incubated with increasing concentrations of PP2 (1, 10, 100 µM) or 200nM 2,3,7,8-tetrachlorodibenzofuran (TCDF) in the presence of 2 nM [ 3 H]TCDD for 1 h at room temperature. Next, reactions were incubated with 250 μl of hydroxyapatite suspension for additional 30 min on ice. Thereafter, reactions were washed three times with 1 ml MEGT buffer (25 mM MOPS, pH 7.5, 1 mM EDTA, 10 % (v/v) glycerol, 0.5 % (v/v) Tween 80). The pellets were transferred into scintillation vials and counted in a scintillation counter. Specific binding was determined as the difference in bound [ 3 H] TCDD between the 'no competitor' and TCDF reaction.
Statistical analyses
If not otherwise indicated, all data shown are mean (±standard deviation) of three or more independent experiments. Data were analyzed using two-sided Student's t test. P values below 0.05 were considered as significant.
